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The modulation of physico-chemical and
biological processes by electrostatic forces is
ubiquitous. Interactions between charged
surfaces start, propagate and end processes
ranging from the preservation, transcription
and translation of genetic information, trans-
membrane signal transduction, oxidative
phosphorylation and energy generation to
apoptosis. The fact that one can read this
editorial is due to a light induced isomerization
event that induces a charge separation of the
protonated Schiff base of the chromophore,
rhodopsin, from its associated counter ion.
The counter ion is the proverbial Zelig because
of the underlying universality of its mechanism
of action. During manufacturing processes, it
affects drug loading into delivery systems, the
quality of polymeric bio-actuation devices
produced and the refolding of denatured
proteins. It  is capable of imposing chirality in
the manufacture of active pharmaceutical
ingredients (APIs),  affecting the aggregation
state of APIs, thereby modulating programmed
release and/or efficacy, altering the quaternary
structure of proteins, thus facilitating
modulated and temporal drug delivery by ligand
activators and possessing the tantalizing
potential to convert mutant proteins to their
native structure or functionality. It can
circumvent cellular membrane barriers
(including endo-lysosomal traps) to drug
translocation, and significantly enhance the
transfection efficiency of genetic or
pseudogenetic material. A review by Apte that
appears in this issue addresses these diverse
effects.
In so far as various permutations and
combinations of cationic and anionic counter
ions can be combined to form different
excipients, ionic liquids being the most manifest
examples, excipient properties and function is,
in no small measure, dependent upon counter
ion components. It would therefore be no
exaggeration to state that some pharmaceutical
excipients will evolve along the trajectory of the
counter ion and counter ion components of
excipients will play specific roles in the
functionality of APIs. Interestingly, this
paradigm of the possibility of 'co-combining'
different components (ions) to make up one
excipient bears scalable and teleological
resemblance to co-processed excipients, where
different excipients are co-processed to make
up a mixture with altered properties.
Attempts to model the wide gamut of effects of
the counter ion after the Hofmeister series have
proven tenuous at best, and non-predictive at
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either not the only contributors to, or part of a
sequence of contributors to, free energy
change. There are relatively few processes
where electrical forces, by themselves, are both
necessary and sufficient to affect physico-
chemical or biological effects. The resulting
(relative) paucity of models does nothing to
detract from their practical and empirical
importance and the contribution of the counter
ion as the mediator of these effects. 
Excipients have increasingly become 'enablers'
of drug delivery and efficacy rather than passive
bystanders. Advances in pharmaceutical
technology have enabled the ability to deliver
specific counter ions (in the form of the
counter ion containing excipient) and the API
simultaneously to preselected targets in the
body. This, coupled with a near universal
mechanism of columbic interactions that
determine the [API- counter ion] efficacy, can
be  harnessed to exploit this hitherto unavai-
lable or unrecognized enabling mechanism.
New excipients may be assembled by a near
inexhaustible supply of different permutations
of counter ions and their judicious use in
specific situations could potentially drive a
renaissance in excipient innovation (and drug
delivery and efficacy) despite regulatory
stagnation. 
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